CASI Pharmaceuticals (CASIF) Inventory (2021 - 2025)
CASI Pharmaceuticals' (CASIF) quarterly Inventory came in at $1.6 million in Q4 2025, down 69.57% YoY from $5.3 million in Q4 2024, and down 38.8% on a QoQ basis from $2.6 million in Q3 2025.
CASI Pharmaceuticals (CASIF) Inventory (2021 - 2025) Analysis & Trends
CASI Pharmaceuticals (CASIF) has 5 years of Inventory data on file, last reported at $1.6 million in Q4 2025.
- Quarterly Inventory fell 69.57% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (down 69.57% YoY) and the FY2025 annual result came in at $1.6 million, down 69.57% from the prior year.
- Inventory slipped to $1.6 million in Q4 2025, from $2.6 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $15.9 billion in Q4 2023 to a low of $1.6 million in Q4 2025.
- A 5-year average of $3.9 billion and a median of $6.1 million in 2022 frame the typical range for Inventory.
- Annual changes were most pronounced in 2023 — Inventory jumped 258567.32% — and 2025, when it sank 99.98%.
- Tracing CASIF's Inventory over 5 years: stood at $1.9 million in 2021, then soared by 221.87% to $6.1 million in 2022, then jumped by 258567.32% to $15.9 billion in 2023, then slumped by 99.97% to $5.3 million in 2024, then sank by 69.57% to $1.6 million in 2025.
- The last three Inventory figures came in at $1.6 million (Q4 2025), $2.6 million (Q3 2025), and $3.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - | 1.84 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 2.61 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Mar 31, 2025 | 4.15 Bn |
| Dec 31, 2024 | 5.25 Mn |
| Jun 30, 2024 | 14.61 Bn |
| Mar 31, 2024 | 15.42 Mn |
| Dec 31, 2023 | 15.88 Bn |
| Jun 30, 2023 | 7.77 Bn |
| Dec 31, 2022 | 6.14 Mn |
| Dec 31, 2021 | 1.91 Mn |